Free cash flow margin rebounded to 33.6% in 2026Q2, with cumulative operating cash flow of $6.8B exceeding net income of $6.5B over ten quarters, though working capital swings and aggressive buybacks ($1.2B in 2026Q2) warrant monitoring.
Zoetis Inc. (ZTS) cash flow statement — 16-year operating, investing & financing cash flows
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|
| Cash from Operations | 3.29B | 2.9B | 2.95B | 2.35B | 1.91B | 2.21B | 2.13B | 1.79B | 1.79B | 1.35B | 713M | 664M | 626M | 681M | 454M | 497M | 254M |
| Operating CF Margin % | - | 30.68% | 31.9% | 27.54% | 23.66% | 28.46% | 31.85% | 28.67% | 30.73% | 25.36% | 14.59% | 13.93% | 13.08% | 14.93% | 10.47% | 11.74% | 7.09% |
| Operating CF Growth % | 82.9% | -1.66% | 25.5% | 23.06% | -13.6% | 4.09% | 18.44% | 0.28% | 32.99% | 88.78% | 7.38% | 6.07% | -8.08% | 50% | -8.65% | 95.67% | - |
| Net Income | 2.62B | 2.67B | 2.5B | 2.34B | 2.11B | 2.03B | 1.64B | 1.5B | 1.42B | 862M | 819M | 339M | 587M | 503M | 436M | 248M | 111M |
| Depreciation & Amortization | 602M | 487M | 497M | 491M | 465M | 448M | 441M | 412M | 308M | 242M | 240M | 199M | 204M | 209M | 200M | 205M | 185M |
| Stock-Based Compensation | 120M | 83M | 74M | 60M | 62M | 58M | 59M | 67M | 53M | 44M | 37M | 43M | 32M | 43M | 28M | 19M | 16M |
| Deferred Taxes | -29M | -52M | -338M | -61M | -286M | -80M | -62M | -79M | -112M | 127M | -55M | -85M | -49M | 23M | -74M | 65M | -68M |
| Other Non-Cash Items | -218M | 121M | 145M | 31M | 259M | 96M | 137M | 46M | 5M | 100M | 111M | 376M | 101M | 7M | 13M | 77M | -90M |
| Working Capital Changes | -404M | -408M | 79M | -512M | -699M | -343M | -85M | -151M | 112M | -29M | -439M | -208M | -157M | -104M | -149M | -117M | 100M |
| Change in Receivables | -320M | -236M | -61M | -102M | -137M | -155M | 74M | -69M | -67M | -50M | 15M | -58M | 69M | -99M | -65M | -85M | 30M |
| Change in Inventory | -282M | -199M | -40M | -361M | -486M | -366M | -346M | -104M | 61M | 19M | -101M | -262M | -16M | -104M | -318M | 40M | 117M |
| Change in Payables | 93M | 46M | 31M | 13M | -29M | -17M | 147M | -10M | 37M | -10M | -28M | 17M | -210M | -82M | 96M | -16M | 25M |
| Cash from Investing | -800M | -748M | -315M | -777M | -883M | -458M | -572M | -504M | -2.26B | -270M | -214M | -1.11B | -187M | -179M | -135M | -449M | -9M |
| Capital Expenditures | -631M | -621M | -655M | -732M | -586M | -477M | -453M | -460M | -338M | -224M | -216M | -224M | -195M | -184M | -126M | -135M | -124M |
| CapEx % of Revenue | 6.63% | 6.56% | 7.08% | 8.57% | 7.25% | 6.13% | 6.79% | 7.35% | 5.8% | 4.22% | 4.42% | 4.7% | 4.08% | 4.03% | 2.91% | 3.19% | 3.46% |
| Acquisitions | -24M | -24M | 285M | -59M | -312M | -14M | -113M | -195M | -2B | -82M | -88M | -883M | 0 | -4M | 0 | -345M | -81M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -46M | -96M | -2M | 6M | 1M | 1M | -432M | -447M | -289M | 36M | 90M | -8M | 8M | 9M | -9M | 31M | 196M |
| Cash from Financing | -3.12B | -1.87B | -2.66B | -3.11B | -904M | -1.86B | 123M | -951M | 533M | -251M | -903M | 755M | -154M | -200M | -78M | -30M | -277M |
| Debt Issued (Net) | 2.27B | 2.27B | -3M | -1.35B | 1.35B | -604M | 744M | -9M | 1.5B | 481M | -405M | 1.11B | 0 | 2.64B | 0 | -143M | 0 |
| Equity Issued (Net) | -4.25B | -3.23B | -1.86B | -1.09B | -1.59B | -743M | -250M | -626M | -698M | -500M | -300M | -203M | 2M | 0 | 0 | 0 | 0 |
| Dividends Paid | -1.11B | -889M | -786M | -692M | -611M | -474M | -380M | -314M | -243M | -206M | -188M | -168M | -146M | -98M | -63M | -416M | -207M |
| Share Repurchases | -4.25B | -3.23B | -1.86B | -1.09B | -1.59B | -743M | -250M | -626M | -698M | -500M | -300M | -203M | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -27M | -14M | -13M | 24M | -49M | -45M | 9M | -2M | -30M | -26M | -10M | 11M | -10M | -2.74B | -15M | 529M | -70M |
| Net Change in Cash | -606M | 325M | -54M | -1.54B | 96M | -119M | 1.67B | 332M | 38M | 837M | -427M | 272M | 272M | 293M | 238M | 16M | -36M |
| Free Cash Flow | 2.66B | 2.28B | 2.3B | 1.62B | 1.33B | 1.74B | 1.67B | 1.33B | 1.45B | 1.12B | 497M | 440M | 431M | 497M | 328M | 362M | 130M |
| FCF Margin % | 27.92% | 24.12% | 24.83% | 18.97% | 16.41% | 22.33% | 25.06% | 21.33% | 24.93% | 21.14% | 10.17% | 9.23% | 9.01% | 10.9% | 7.56% | 8.55% | 3.63% |
| FCF Growth % | 19.74% | -0.65% | 41.76% | 22.25% | -23.62% | 3.77% | 25.32% | -8.06% | 29.41% | 125.75% | 12.95% | 2.09% | -13.28% | 51.52% | -9.39% | 178.46% | - |
| FCF per Share | 6.36 | 5.14 | 5.05 | 3.51 | 2.82 | 3.64 | 3.50 | 2.77 | 2.98 | 2.28 | 1.00 | 0.88 | 0.86 | 0.99 | 0.66 | 0.75 | 0.27 |
| FCF Conversion (FCF/Net Income) | 1.02x | 1.09x | 1.19x | 1.00x | 0.90x | 1.09x | 1.30x | 1.20x | 1.25x | 1.56x | 0.87x | 1.96x | 1.07x | 1.35x | 1.04x | 2.03x | 2.31x |
| Interest Paid | 381M | 261M | 274M | 295M | 242M | 253M | 257M | 247M | 190M | 167M | 165M | 117M | 118M | 60M | 31M | 37M | 37M |
| Taxes Paid | 720M | 715M | 892M | 754M | 638M | 548M | 418M | 418M | 336M | 455M | 408M | 224M | 278M | 134M | 276M | 142M | 209M |
Quick answers to the most common questions about buying ZTS stock.
Zoetis Inc. (ZTS) generated $2.90B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Zoetis Inc. (ZTS) generated $2.28B in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Zoetis Inc. (ZTS) spent $621.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Zoetis Inc. (ZTS) returned $889.0M to shareholders via cash dividends and spent $3.23B on share repurchases. This shows the company's commitment to returning capital to its equity investors.
Key Metrics
Top Statement Risk
Revenue growth stagnation
Metrics are mathematically derived from official filings.
Cash Conversion Volatility Signals Working Capital Drag
Zoetis' operating cash flow to net income ratio swung from 1.53 in 2026Q2 to 0.67 in 2026Q1, as per SEC filings, indicating quarterly earnings quality is heavily influenced by working capital swings.
The OCF/NI ratio has been erratic, ranging from 0.67 to 1.56 over the past ten quarters, with the most recent quarter showing a strong recovery. This volatility appears tied to working capital changes, which have been negative in most quarters, suggesting that cash conversion is not consistently strong. Investors should monitor whether this pattern reflects seasonal inventory builds or a more persistent issue with receivables collection.
Free Cash Flow Rebound Masks Underlying Stagnation
FCF margin improved to 33.6% in 2026Q2 from 12.5% in 2025Q2, based on reported figures, but the two-year trend shows a plateau, with quarterly FCF averaging around $570M.
The recent quarter's FCF surge is largely due to a favorable working capital swing, as operating cash flow jumped to $1.1B. However, excluding this effect, FCF generation appears stable but not accelerating, consistent with the prior income statement analysis of low single-digit revenue growth. The FCF margin remains well above peers like ELAN and PAHC, but the lack of growth may limit multiple expansion.
Capital Intensity Steady, Growth Capex Modest
CapEx as a percentage of revenue has hovered between 4.9% and 9.3% over the last ten quarters, as reported in financial statements, indicating a mature asset base with limited expansionary investment.
The capital expenditure ratio is relatively low for a manufacturer, suggesting that Zoetis is not in a heavy investment phase. This implies that most CapEx is likely maintenance-oriented, supporting the view that growth is being driven by existing product lines rather than new capacity. The stable capital intensity also supports the strong FCF margins, but it may limit future organic growth if capacity constraints emerge.
Working Capital Swings Drive Cash Flow Timing
Working capital changes have been negative in seven of the last ten quarters, with the largest drag of -$415M in 2025Q2, according to SEC filings, indicating persistent cash outflows from operational needs.
The recurring negative working capital changes suggest that Zoetis is investing in inventory or extending receivables, which may be a function of its distribution network. The positive swings in 2025Q4 and 2024Q4 appear to be seasonal, but the overall trend points to a structural drag on cash flow. This warrants monitoring as it could indicate deteriorating efficiency in collections or inventory management.
Aggressive Buybacks Outpace Dividend Growth
Zoetis spent $1.2B on buybacks in 2026Q2 alone, nearly triple the $447M in dividends, as per financial statements, signaling a strong preference for returning capital via repurchases.
The buyback pace has been aggressive, with cumulative buybacks of $5.4B over the last ten quarters, far exceeding dividends of $2.3B. This suggests management is confident in the stock's value, but it also reduces the cash available for other uses. The dividend has grown modestly, but the yield remains low relative to peers, indicating that shareholders are relying on capital appreciation rather than income.
Cumulative Cash Generation Exceeds Net Income
Over the last ten quarters, cumulative operating cash flow of $6.8B exceeds cumulative net income of $6.5B, based on reported figures, indicating high earnings quality overall.
The small positive cumulative gap between OCF and net income suggests that Zoetis' earnings are well-backed by cash, with D&A and SBC adding back more than working capital consumes. However, the quarterly volatility in this gap highlights that timing differences can be significant. This supports the view that the company's earnings quality is solid, but investors should be aware of the potential for working capital to distort quarterly comparisons.
What Could Invalidate the Base Case
Despite strong cash generation, Zoetis' reliance on buybacks and working capital swings may obscure underlying stagnation, as per SEC filings, warranting scrutiny of revenue growth and capital allocation.
The cash flow statement reveals that aggressive buybacks and favorable working capital timing have supported FCF, but the underlying revenue growth remains stagnant at 0.3% in 2026Q2. If working capital swings reverse or buybacks are curtailed, cash flow could weaken, challenging the premium valuation. Investors should monitor whether the company can translate its strong margins into sustainable growth, as the current cash flow strength may be partly a function of financial engineering rather than operational momentum.